Table 1.
Peptides from FBXO25, Skp1, CUL1, CAND1, and β-actin identified in MS/MS analyses.
| CAND1 (EMBL-EBI: IPI00100160.3) | ||||
|---|---|---|---|---|
| m/z | z | Peptides | Position in Protein | Xcorr |
| 663.78760 | 2 | R.AVAALLTIPEAEK.S | 1179 - 1191 | 2.667 |
| 605.76672 | 2 | R.HEM*LPEFYK.T | 365 - 373 | 2.608 |
| 772.40698 | 2 | K.ITSEALLVTQQLVK.V | 535 - 548 | 2.568 |
| 742.83862 | 2 | K.ISGSILNELIGLVR.S | 730 - 743 | 2.568 |
| 629.24707 | 2 | K.LGTLSALDILIK.N | 668 - 679 | 2.137 |
| 861.86407 | 2 | K.FTISDHPQPIDPLLK.N | 991 - 1005 | 2.126 |
| 586.67407 | 2 | K.TLEDPDLNVR.R | 1014 - 1023 | 2.070 |
| 743.95496 | 2 | K.EGPAVVGQFIQDVK.N | 813 - 826 | 2.015 |
| CUL1 (EMBL-EBI: IPI00014310.3) | ||||
| 757.79089 | 2 | K.M*DILAQVLQILLK.S | 633 - 645 | 4.911 |
| 981.25537 | 2 | R.ESTEFLQQNPVTEYM*K.K | 247 - 262 | 4.159 |
| 780.72217 | 2 | K.ESFESQFLADTER.F | 230 - 242 | 3.710 |
| 894.97229 | 2 | K.LLETHIHNQGLAAIEK.C | 339 - 354 | 3.673 |
| 855.62659 | 2 | K.HQQLLGEVLTQLSSR.F | 727 - 741 | 3.411 |
| 1124.73144 | 2 | K.YNALVM*SAFNNDAGFVAALDK.A | 377 - 397 | 3.121 |
| 833.33325 | 2 | K.GQTPGGAQFVGLELYK.R | 75 - 90 | 3.072 |
| 1116.46899 | 2 | K.YNALVMSAFNNDAGFVAALDK.A | 377 - 397 | 2.997 |
| 521.16315 | 2 | R.M*FQDIGVSK.D | 507 - 515 | 2.948 |
| 895.33618 | 2 | R.VQVYLHESTQDELAR.K | 275 - 289 | 2.752 |
| 675.36792 | 2 | K.M*YVQTVLDVHK.K | 365 - 375 | 2.731 |
| 737.12897 | 2 | K.QIGLDQIWDDLR.A | 14 - 25 | 2.709 |
| 1036.00842 | 2 | K.HLEIFHTEFQNLLDADK.N | 299 - 315 | 2.634 |
| 487.12463 | 2 | R.IQDGLGELK.K | 329 - 337 | 2.616 |
| 718.69324 | 2 | K.FYTQQWEDYR.F | 118 - 127 | 2.566 |
| 518.64606 | 2 | R.AGIQQVYTR.Q | 26 - 34 | 2.518 |
| 667.16626 | 2 | K.MYVQTVLDVHK.K | 365 - 375 | 2.456 |
| 1111.37231 | 2 | K.NPEEAELEDTLNQVM*VVFK.Y | 436 - 454 | 2.386 |
| 980.85632 | 2 | R.ESTEFLQQNPVTEYM*K.K | 247 - 262 | 2.366 |
| 676.50354 | 2 | K.DGEDLMDESVLK.F | 106 - 117 | 2.281 |
| 643.25110 | 2 | K.YIEDKDVFQK.F | 455 - 464 | 2.247 |
| 952.56689 | 2 | R.LVHQNSASDDAEASMISK.L | 474 - 491 | 2.186 |
| 897.86658 | 2 | K.KGQTPGGAQFVGLELYK.R | 74 - 90 | 2.647 |
| 576.74609 | 2 | K.LTWLYQLSK.G | 579 - 587 | 2.032 |
| FBXO25 (EMBL-EBI: IPI00014310.3) | ||||
| 633.48407 | 2 | R.LDFSSAIQDIR.R | 43 - 53 | 4.321 |
| 1012.09888 | 3 | K.DSGHPCTAADPDSCFTPVSPQHFIDLFK.F | 263 - 290 | 3.774 |
| 610.19012 | 2 | K.SQLTSLSGVAQK.N | 68 - 79 | 3.197 |
| 609.92322 | 2 | K.SQLTSLSGVAQK.N | 68 - 79 | 3.075 |
| 610.32690 | 2 | K.SQLTSLSGVAQK.N | 68 - 79 | 3.020 |
| 633.14581 | 2 | R.LDFSSAIQDIR.R | 43 - 53 | 3.011 |
| 514.23706 | 2 | K.NYFNILDK.I | 80 - 87 | 2.851 |
| 744.60583 | 2 | K.SVLVGNINIWICR.L | 123 - 135 | 2.562 |
| 514.23907 | 2 | K.NYFNILDK.I | 80 - 87 | 2.383 |
| 633.43774 | 2 | R.LDFSSAIQDIR.R | 43 - 53 | 2.240 |
| 633.55469 | 2 | R.LDFSSAIQDIR.R | 43 - 53 | 2.222 |
| 514.28241 | 2 | K.NYFNILDK.I | 80 - 87 | 2.070 |
| SKP1 (NCBI- gi| 25777711) | ||||
| 940.41064 | 2 | K.LQSSDGEIFEVDVEIAK.Q | 5 - 21 | 4.412 |
| 713.33685 | 3 | K.VDQGTLFELILAANYLDIK.G | 94 - 112 | 3.816 |
| 940.95300 | 2 | K.LQSSDGEIFEVDVEIAK.Q | 5 - 21 | 3.371 |
| 882.32397 | 2 | K.RTDDIPVWDQEFLK.V | 80 - 93 | 3.358 |
| 1068.98218 | 2 | K.VDQGTLFELILAANYLDIK.G | 94 - 112 | 3.257 |
| 940.32556 | 2 | K.LQSSDGEIFEVDVEIAK.Q | 5 - 21 | 2.869 |
| 940.25732 | 2 | K.LQSSDGEIFEVDVEIAK.Q | 5 - 21 | 2.787 |
| 940.34827 | 2 | K.LQSSDGEIFEVDVEIAK.Q | 5 - 21 | 2.212 |
| 803.73047 | 2 | R.TDDIPVWDQEFLK.V | 81 - 93 | 2.034 |
| β-actin (EMBL-EBI: IPI00021439.1) | ||||
| 1116.76733 | 2 | K.DLYANTVLSGGTTM*YPGIADR.M | 292 - 312 | 4.019 |
| 978.17908 | 2 | R.VAPEEHPVLLTEAPLNPK.A | 96 - 113 | 3.678 |
| 1062.34473 | 3 | R.TTGIVMDSGDGVTHTVPIYEGYALPHAILR.L | 148 - 177 | 3.151 |
| 759.21936 | 2 | K.QEYDESGPSIVHR.K | 360 - 372 | 2.678 |
| 1172.37195 | 2 | R.KDLYANTVLSGGTTMYPGIADR.M | 291 - 312 | 2.558 |
| 567.06982 | 2 | R.GYSFTTTAER.E | 197 - 206 | 2.499 |
| 1116.57044 | 2 | K.DLYANTVLSGGTTM*YPGIADR.M | 292 - 312 | 2.149 |